Australia's Therapeutic Goods Administration seeks to tighten 3-D printed implant regulations

Written by Mackenzie Garrity | November 13, 2017 | Print  |

Australia's Therapeutic Goods Administration proposed a regulatory change regarding personalized and 3-D printed medical devices and implants, according to the 3D Printing Industry.

Here are five things to know:


1. After concerns current regulatory guidelines are not satisfying goals to "mitigate risks to patients, and to meet requirements for healthcare providers and manufactures," the TGA hopes to redefine personalized devices and clarify requirements for high and low risk medical devices.


2. Currently, 3-D printed implants are considered low risk custom devices because of a loophole in existing regulation. New regulations would classify these implants as high risk devices.


3. Along with redefining personalized devices, the TGA redefining what constitutes as a manufacturer. The new definition would require anyone who modifies a device already on the market to be liable for the same responsibility as the original equipment manufacturer.


4. The new regulations do not affect mass produced 3-D devices, such as Stryker's posterior lumbar cages or SI-Bone hip implants, because the devices are not personalized on a per-patient basis.


5. Additionally, there are proposals for new guidelines for devices with "human material," such as bioprinted scaffolds, and new classification for anatomical models and digital 3-D printed files.


More articles on devices and implants:
Mazor, J&J, Globus Medical & more: 6 device company notes
Titan Medical reports $4M in research, development expenses in Q3 2017: 4 notes
Stryker's LFIT V40 Femoral Head lawsuits continue to move forward: 4 takeaways

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers